PRESS RELEASE published on 11/05/2025 at 17:56, 3 months 5 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO SCHOTT Pharma AG & Co. KGaA appoints Christian Mias as CEO to succeed Andreas Reisse, effective May 1, 2026. Inside information disclosed. Press release via EQS News Inside Information CEO Appointment SCHOTT Pharma EQS News Christian Mias
BRIEF published on 08/12/2025 at 07:05, 5 months 30 days ago SCHOTT Pharma annonce des résultats stables au troisième trimestre 2025 Innovation SCHOTT Pharma Solutions À Haute Valeur Ajoutée Confinement Des Drogues Résultats Du Troisième Trimestre 2025
BRIEF published on 08/12/2025 at 07:05, 5 months 30 days ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
PRESS RELEASE published on 08/12/2025 at 07:00, 5 months 30 days ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
BRIEF published on 08/05/2025 at 10:00, 6 months 6 days ago SCHOTT Pharma's Q3 2025 Highlights and FY 2025 Outlook Revenue Growth EBITDA Margin Financial Outlook Q3 2025 High Value Solutions
BRIEF published on 08/05/2025 at 10:00, 6 months 6 days ago Faits marquants du troisième trimestre 2025 et perspectives pour l'exercice 2025 de SCHOTT Pharma Marge EBITDA Croissance Des Revenus Solutions À Haute Valeur Ajoutée Perspectives Financières T3 2025
BRIEF published on 08/05/2025 at 09:58, 6 months 6 days ago SCHOTT Pharma met à jour ses prévisions de chiffre d'affaires et d'EBITDA pour l'exercice 2025 Résultats Financiers SCHOTT Pharma Marge EBITDA Croissance Des Revenus Orientations Pour L'exercice 2025
BRIEF published on 08/05/2025 at 09:58, 6 months 6 days ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:55, 6 months 6 days ago SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance SCHOTT Pharma reports Q3 2025 revenues up 3% yoy at EUR 256m and gives FY 2025 guidance with EBITDA expected to be around 28.0%. Full financial results to be published on August 12, 2025 Revenues EBITDA SCHOTT Pharma Q3 2025 FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:53, 6 months 6 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin SCHOTT Pharma AG & Co. KGaA specifies FY 2025 guidance for revenue growth and EBITDA margin, expecting 6.0% organic revenue growth and 28.0% EBITDA margin Revenue Growth EBITDA Margin SCHOTT Pharma Guidance FY 2025
Published on 02/11/2026 at 14:00, 11 minutes ago Organto Foods Inc. Expands Scalable and Flexible Logistics Platform to Support 2026 Growth
Published on 02/11/2026 at 14:00, 11 minutes ago PPX Mining Provides Operational and Corporate Update
Published on 02/11/2026 at 14:00, 11 minutes ago Meta Critical Minerals Engages Quad Consulting Group to Advance Table Mountain Silica Project Development Strategy
Published on 02/11/2026 at 13:30, 41 minutes ago Alset AI's Lyken.AI Signs Formal Cloud Compute Services Contract with Leading Multinational Technology and Telecommunications Company, Commences Service Delivery
Published on 02/11/2026 at 13:30, 41 minutes ago Nextech3D.ai Announces Live Earnings Q&A with CEO Following Q4 Results on February 19, 2026
Published on 02/11/2026 at 13:51, 19 minutes ago EQS-Adhoc: Berentzen-Gruppe Aktiengesellschaft: Preliminary operating results 2025
Published on 02/11/2026 at 11:30, 2 hours 41 minutes ago EcoGraf Signs Co-operation Agreement with European Investment Bank
Published on 02/11/2026 at 11:01, 3 hours 9 minutes ago New life for freight railway line in Australia - Vossloh supplies concrete sleepers for the Maroona to Portland connection
Published on 02/11/2026 at 11:25, 2 hours 45 minutes ago Innelec : Mise à disposition du rapport financier semestriel 2025-26
Published on 02/11/2026 at 08:00, 6 hours 11 minutes ago Imerys-press-release French State acquisition stake Emili Lithium
Published on 02/11/2026 at 08:00, 6 hours 11 minutes ago Imerys-communique-de-presse prise participation Etat Français Projet lithium Emili
Published on 02/10/2026 at 18:24, 19 hours 46 minutes ago Mersen: Number of shares and voting rights as of January 31, 2026
Published on 02/10/2026 at 18:24, 19 hours 46 minutes ago Mersen : nombre d'actions et de droits de vote au 31 janvier 2026
